de Roos B, Rucklidge G, Reid M, Ross K, Duncan G, Navarro M A, Arbones-Mainar J M, Guzman-Garcia M A, Osada J, Browne J, Loscher C E, Roche H M
Rowett Research Institute, Aberdeen, UK.
FASEB J. 2005 Oct;19(12):1746-8. doi: 10.1096/fj.05-3953fje. Epub 2005 Jul 29.
Conjugated linoleic acids (CLA) affect atherogenesis, but mechanisms are not well understood. We explored how two isomers of CLA, cis9, trans11-CLA and trans10, cis12-CLA, affected lipid and glucose metabolism, as well as hepatic protein expression, in apolipoprotein E knockout mice. After 12 wk of intervention, plasma triglyceride, NEFA, and glucose concentrations were significantly higher in the trans10, cis12-CLA group, whereas plasma triglyceride, NEFA, glucose, and insulin concentrations were significantly lower in the cis9, trans11-CLA group, compared with control mice consuming linoleic acid. Proteomics identified significant up- or down-regulation of 113 liver cytosolic proteins by either CLA isomer. Principal component analysis revealed that the treatment effect of cis9, trans11-CLA was mainly explained by the up-regulation of different posttranslational forms of heat shock protein 70 kD. In contrast, the treatment effect of trans10, cis12-CLA was mainly explained by up-regulation of key enzymes in the gluconeogenic, beta-oxidation, and ketogenesic pathways. Correlation analysis again emphasized the divergent effects of both CLA isomers on different pathways, but also revealed a linkage between insulin resistance and increased levels of hepatic serotransferrin. Thus, our systems biology approach provided novel insights into the mechanisms by which individual CLA isomers differentially affect pathways related to atherogenesis, such as insulin resistance and inflammation.
共轭亚油酸(CLA)会影响动脉粥样硬化的发生,但其机制尚未完全明确。我们探究了CLA的两种异构体,即顺式9,反式11 - CLA和反式10,顺式12 - CLA,对载脂蛋白E基因敲除小鼠的脂质和葡萄糖代谢以及肝脏蛋白表达的影响。经过12周的干预后,与食用亚油酸的对照小鼠相比,反式10,顺式12 - CLA组的血浆甘油三酯、非酯化脂肪酸(NEFA)和葡萄糖浓度显著更高,而顺式9,反式11 - CLA组的血浆甘油三酯、NEFA、葡萄糖和胰岛素浓度显著更低。蛋白质组学鉴定出两种CLA异构体分别使113种肝脏胞质蛋白发生显著上调或下调。主成分分析显示,顺式9,反式11 - CLA的治疗效果主要由不同翻译后形式的70 kD热休克蛋白的上调来解释。相比之下,反式10,顺式12 - CLA的治疗效果主要由糖异生、β - 氧化和生酮途径中的关键酶上调来解释。相关性分析再次强调了两种CLA异构体对不同途径的不同影响,但也揭示了胰岛素抵抗与肝脏血清转铁蛋白水平升高之间的联系。因此,我们的系统生物学方法为单个CLA异构体差异影响与动脉粥样硬化相关途径(如胰岛素抵抗和炎症)的机制提供了新的见解。